chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Abdominal distension, Diarrhoea, Flatulence
Clinical narrative: Diarrhea; Super gassy/Passing gas; Bloated; Tummy was like big; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), FLATULENCE (Super gassy/Passing gas), ABDOMINAL DISTENSION (Bloated) and ABDOMINAL DISCOMFORT (Tummy was like big) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007C21A and 017B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 03-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-May-2021, the patient experienced DIARRHOEA (Diarrhea), FLATULENCE (Super gassy/Passing gas), ABDOMINAL DISTENSION (Bloated) and ABDOMINAL DISCOMFORT (Tummy was like big). At the time of the report, DIARRHOEA (Diarrhea), FLATULENCE (Super gassy/Passing gas), ABDOMINAL DISTENSION (Bloated) and ABDOMINAL DISCOMFORT (Tummy was like big) had resolved. Unknown          Concomitant medications includes Pain medicine. Treatment medication reported includes Ammodium .   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2021: TCR form added. Events outcome was updated.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Inappropriate schedule of product administration, Muscle twitching, Somnolence
Clinical narrative: received 2nd dose 3 months after 1st dose; extreme sleepiness; leg twitching; chills; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received 2nd dose 3 months after 1st dose), SOMNOLENCE (extreme sleepiness), MUSCLE TWITCHING (leg twitching) and CHILLS (chills) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040B21A and 011J20A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received 2nd dose 3 months after 1st dose), SOMNOLENCE (extreme sleepiness), MUSCLE TWITCHING (leg twitching) and CHILLS (chills). On 09-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received 2nd dose 3 months after 1st dose) had resolved. On 11-Apr-2021, SOMNOLENCE (extreme sleepiness), MUSCLE TWITCHING (leg twitching) and CHILLS (chills) had resolved.            Concomitant information were not provided. Treatment information were not provided.   This case was linked to MOD-2021-114207 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2021: Additional information include event outcome with no new information.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Nausea, Pyrexia, Vaccination site erythema
Clinical narrative: Hot injection site; huge lump on arm where the vaccine was administered; Chills; fever; nausea; headache; Extremely sore injection site; Red injection site; Swollen injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot injection site), VACCINATION SITE MASS (huge lump on arm where the vaccine was administered), CHILLS (Chills), PYREXIA (fever) and NAUSEA (nausea) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, the patient experienced VACCINATION SITE WARMTH (Hot injection site), VACCINATION SITE MASS (huge lump on arm where the vaccine was administered), CHILLS (Chills), PYREXIA (fever), NAUSEA (nausea), HEADACHE (headache), VACCINATION SITE PAIN (Extremely sore injection site), VACCINATION SITE ERYTHEMA (Red injection site) and VACCINATION SITE SWELLING (Swollen injection site). At the time of the report, VACCINATION SITE WARMTH (Hot injection site), VACCINATION SITE MASS (huge lump on arm where the vaccine was administered), CHILLS (Chills), PYREXIA (fever), NAUSEA (nausea), HEADACHE (headache), VACCINATION SITE PAIN (Extremely sore injection site), VACCINATION SITE ERYTHEMA (Red injection site) and VACCINATION SITE SWELLING (Swollen injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. Treatment with Tylenol and Ibuprofen were taken to alleviate the symptoms.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site mass, Vaccination site pain, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Hot injection site; huge lump on arm where the vaccine was administered; Chills; fever; nausea; headache; Extremely sore injection site; Red injection site; Swollen injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot injection site), VACCINATION SITE MASS (huge lump on arm where the vaccine was administered), CHILLS (Chills), PYREXIA (fever) and NAUSEA (nausea) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, the patient experienced VACCINATION SITE WARMTH (Hot injection site), VACCINATION SITE MASS (huge lump on arm where the vaccine was administered), CHILLS (Chills), PYREXIA (fever), NAUSEA (nausea), HEADACHE (headache), VACCINATION SITE PAIN (Extremely sore injection site), VACCINATION SITE ERYTHEMA (Red injection site) and VACCINATION SITE SWELLING (Swollen injection site). At the time of the report, VACCINATION SITE WARMTH (Hot injection site), VACCINATION SITE MASS (huge lump on arm where the vaccine was administered), CHILLS (Chills), PYREXIA (fever), NAUSEA (nausea), HEADACHE (headache), VACCINATION SITE PAIN (Extremely sore injection site), VACCINATION SITE ERYTHEMA (Red injection site) and VACCINATION SITE SWELLING (Swollen injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. Treatment with Tylenol and Ibuprofen were taken to alleviate the symptoms.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Neuropathy peripheral, Swelling
Clinical narrative: left leg has been worse than regular neuropathy; swelling; red area on her left arm above the injection site; Fatigue that is worse than usual; bad headache that are worse than usual; muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of NEUROPATHY PERIPHERAL (left leg has been worse than regular neuropathy), SWELLING (swelling), VACCINATION SITE ERYTHEMA (red area on her left arm above the injection site), FATIGUE (Fatigue that is worse than usual) and HEADACHE (bad headache that are worse than usual) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  The patient's past medical history included Neuropathy. Concomitant products included FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF) from 27-Apr-2021 to an unknown date, CLONAZEPAM, BUSPIRONE, AMLODIPINE, CYANOCOBALAMIN (B 12), ACETYLSALICYLIC ACID (ASPIRIN 81), VITAMIN B COMPLEX (SUPER B COMPLEX [VITAMIN B COMPLEX]), VITAMIN D3, VITAMIN C [ASCORBIC ACID], MAGNESIUM and GARLIC [ALLIUM SATIVUM] for an unknown indication.    On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NEUROPATHY PERIPHERAL (left leg has been worse than regular neuropathy), SWELLING (swelling), VACCINATION SITE ERYTHEMA (red area on her left arm above the injection site), FATIGUE (Fatigue that is worse than usual), HEADACHE (bad headache that are worse than usual) and MYALGIA (muscle pain). At the time of the report, NEUROPATHY PERIPHERAL (left leg has been worse than regular neuropathy), SWELLING (swelling), VACCINATION SITE ERYTHEMA (red area on her left arm above the injection site), FATIGUE (Fatigue that is worse than usual), HEADACHE (bad headache that are worse than usual) and MYALGIA (muscle pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Medical history includes compromised immune system. No treatment provided by the reporter. Company Comment: Limited information regarding the events has been provided at this time and a causal relationship cannot be excluded   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Follow up added on 01 May 2021 had no new information.; Sender's Comments: Limited information regarding the events has been provided at this time and a causal relationship cannot be excluded
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: left leg has been worse than regular neuropathy; swelling; red area on her left arm above the injection site; Fatigue that is worse than usual; bad headache that are worse than usual; muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of NEUROPATHY PERIPHERAL (left leg has been worse than regular neuropathy), SWELLING (swelling), VACCINATION SITE ERYTHEMA (red area on her left arm above the injection site), FATIGUE (Fatigue that is worse than usual) and HEADACHE (bad headache that are worse than usual) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  The patient's past medical history included Neuropathy. Concomitant products included FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF) from 27-Apr-2021 to an unknown date, CLONAZEPAM, BUSPIRONE, AMLODIPINE, CYANOCOBALAMIN (B 12), ACETYLSALICYLIC ACID (ASPIRIN 81), VITAMIN B COMPLEX (SUPER B COMPLEX [VITAMIN B COMPLEX]), VITAMIN D3, VITAMIN C [ASCORBIC ACID], MAGNESIUM and GARLIC [ALLIUM SATIVUM] for an unknown indication.    On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NEUROPATHY PERIPHERAL (left leg has been worse than regular neuropathy), SWELLING (swelling), VACCINATION SITE ERYTHEMA (red area on her left arm above the injection site), FATIGUE (Fatigue that is worse than usual), HEADACHE (bad headache that are worse than usual) and MYALGIA (muscle pain). At the time of the report, NEUROPATHY PERIPHERAL (left leg has been worse than regular neuropathy), SWELLING (swelling), VACCINATION SITE ERYTHEMA (red area on her left arm above the injection site), FATIGUE (Fatigue that is worse than usual), HEADACHE (bad headache that are worse than usual) and MYALGIA (muscle pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Medical history includes compromised immune system. No treatment provided by the reporter. Company Comment: Limited information regarding the events has been provided at this time and a causal relationship cannot be excluded   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Follow up added on 01 May 2021 had no new information.; Sender's Comments: Limited information regarding the events has been provided at this time and a causal relationship cannot be excluded
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Gave vaccine to 17 year old patient; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Gave vaccine to 17 year old patient) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. C27C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Gave vaccine to 17 year old patient). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Gave vaccine to 17 year old patient) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant and treatment details were provided.   Most recent FOLLOW-UP information incorporated above includes: On 13-Jun-2021: Non-significant Follow up Appended
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Joint swelling, Musculoskeletal discomfort, Myalgia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (swelling in right shoulder joint), MUSCULOSKELETAL DISCOMFORT (right should joint pain that gets worse with movement), ARTHRALGIA (left shoulder joint pain that comes and goes, shoulder still hurts when move in certain ways) and MYALGIA (still hurts when i move my arm certain ways.) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010A21A and 013M20A) for COVID-19 vaccination. No medical history provided by reporter. Concomitant products included LOSARTAN, METOPROLOL, ACETYLSALICYLIC ACID (BABY ASPIRIN), METFORMIN, CLARITHROMYCIN (MACROBID [CLARITHROMYCIN]), ATORVASTATIN, FISH OIL, MULTIVITAMINS [VITAMINS NOS], VITAMIN C [ASCORBIC ACID], UBIDECARENONE (COQ10 [UBIDECARENONE]), CURCUMA LONGA (TURMERIC [CURCUMA LONGA]), ALLIUM SATIVUM POWDER (GARLIC (ODOURLESS)) and ASCORBIC ACID, ZINC OXIDE (IMMUNE BOOST) for an unknown indication. On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Mar-2021, the patient experienced ARTHRALGIA (left shoulder joint pain that comes and goes, shoulder still hurts when move in certain ways). On an unknown date, the patient experienced JOINT SWELLING (swelling in right shoulder joint), MUSCULOSKELETAL DISCOMFORT (right should joint pain that gets worse with movement) and MYALGIA (still hurts when i move my arm certain ways.). The patient was treated with SULFAMETHOXAZOLE, TRIMETHOPRIM (MORTIN) for Joint pain, at an unspecified dose and frequency; Physical therapy for Musculoskeletal discomfort and Physical therapy for Arthralgia. At the time of the report, JOINT SWELLING (swelling in right shoulder joint) and MYALGIA (still hurts when i move my arm certain ways.) outcome was unknown and MUSCULOSKELETAL DISCOMFORT (right should joint pain that gets worse with movement) and ARTHRALGIA (left shoulder joint pain that comes and goes, shoulder still hurts when move in certain ways) had not resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Most recent FOLLOW-UP information incorporated above includes: On 10-Jul-2021: Follow up was received added new events and treatment information.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (sore arm) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included RIVAROXABAN (XARELTO), ATENOLOL, LISINOPRIL and TAMSULOSIN for an unknown indication.    On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-May-2021, the patient experienced MYALGIA (sore arm). At the time of the report, MYALGIA (sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Poor quality sleep
Clinical narrative: Felt like did not sleep; Totally wiped out; Totally exhausted; This spontaneous case was reported by a consumer and describes the occurrence of POOR QUALITY SLEEP (Felt like did not sleep), FEELING ABNORMAL (Totally wiped out) and FATIGUE (Totally exhausted) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Apr-2021, the patient experienced POOR QUALITY SLEEP (Felt like did not sleep), FEELING ABNORMAL (Totally wiped out) and FATIGUE (Totally exhausted). At the time of the report, POOR QUALITY SLEEP (Felt like did not sleep), FEELING ABNORMAL (Totally wiped out) and FATIGUE (Totally exhausted) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Balance disorder, Dizziness, Feeling cold, Hot flush
Clinical narrative: totally weak; dizziness; imbalance; hot flashes; freezing to bed; nausea; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (totally weak), DIZZINESS (dizziness), BALANCE DISORDER (imbalance), HOT FLUSH (hot flashes) and FEELING COLD (freezing to bed) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included RANOLAZINE, CLOPIDOGREL, SERTRALINE, LEVOTHYROXINE, GABAPENTIN, METOPROLOL, Cholesterol medication and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, the patient experienced ASTHENIA (totally weak), DIZZINESS (dizziness), BALANCE DISORDER (imbalance), HOT FLUSH (hot flashes), FEELING COLD (freezing to bed) and NAUSEA (nausea). At the time of the report, ASTHENIA (totally weak), DIZZINESS (dizziness), BALANCE DISORDER (imbalance), HOT FLUSH (hot flashes), FEELING COLD (freezing to bed) and NAUSEA (nausea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: totally weak; dizziness; imbalance; hot flashes; freezing to bed; nausea; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (totally weak), DIZZINESS (dizziness), BALANCE DISORDER (imbalance), HOT FLUSH (hot flashes) and FEELING COLD (freezing to bed) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included RANOLAZINE, CLOPIDOGREL, SERTRALINE, LEVOTHYROXINE, GABAPENTIN, METOPROLOL, Cholesterol medication and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, the patient experienced ASTHENIA (totally weak), DIZZINESS (dizziness), BALANCE DISORDER (imbalance), HOT FLUSH (hot flashes), FEELING COLD (freezing to bed) and NAUSEA (nausea). At the time of the report, ASTHENIA (totally weak), DIZZINESS (dizziness), BALANCE DISORDER (imbalance), HOT FLUSH (hot flashes), FEELING COLD (freezing to bed) and NAUSEA (nausea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever 101.3°F; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever 101.3°F) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 005021A) for COVID-19 vaccination.     The patient's past medical history included Pneumonia in March 2020 and Surgery (Lung Surgery) in September 2020.    On 07-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-May-2021, the patient experienced PYREXIA (Fever 101.3°F). At the time of the report, PYREXIA (Fever 101.3°F) outcome was unknown. Not Provided        No concomitant medication was reported.Treatment medication was not provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Sensitive skin, Tenderness
Clinical narrative: tender; Sensitive; Rash feels tender and sensitive; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (tender), SENSITIVE SKIN (Sensitive) and RASH (Rash feels tender and sensitive) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 00HC21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included METFORMIN and AMLODIPINE for an unknown indication.   On 04-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-May-2021, the patient experienced TENDERNESS (tender), SENSITIVE SKIN (Sensitive) and RASH (Rash feels tender and sensitive). At the time of the report, TENDERNESS (tender), SENSITIVE SKIN (Sensitive) and RASH (Rash feels tender and sensitive) outcome was unknown.        Action taken with response to the events were not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: did not receive the second dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (did not receive the second dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (did not receive the second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (did not receive the second dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment and concomitant drug information were given.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site rash, Rash
Clinical narrative: Rash below site of injection, size of a silver dollar; Rash at injection site was pinkish in color; Small rash on middle of stomach; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Small rash on middle of stomach), INJECTION SITE RASH (Rash below site of injection, size of a silver dollar) and INJECTION SITE ERYTHEMA (Rash at injection site was pinkish in color) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, the patient experienced RASH (Small rash on middle of stomach). On 29-Apr-2021, the patient experienced INJECTION SITE RASH (Rash below site of injection, size of a silver dollar) and INJECTION SITE ERYTHEMA (Rash at injection site was pinkish in color). On 24-Apr-2021, RASH (Small rash on middle of stomach) had resolved. On 30-Apr-2021, INJECTION SITE RASH (Rash below site of injection, size of a silver dollar) and INJECTION SITE ERYTHEMA (Rash at injection site was pinkish in color) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: second vaccine mild pain on injection site almost gone; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (second vaccine mild pain on injection site almost gone) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026C21A and 39A21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension. Concomitant products included LISINOPRIL for an unknown indication.   On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (second vaccine mild pain on injection site almost gone). At the time of the report, VACCINATION SITE PAIN (second vaccine mild pain on injection site almost gone) had resolved. Unknown          No treatment medications were reported Action taken with mRNA-1273 in response to the events were Not Applicable    This case was linked to MOD-2021-114245 (Patient Link).
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: Fever; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and MYALGIA (Body aches) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever) and MYALGIA (Body aches). At the time of the report, PYREXIA (Fever) and MYALGIA (Body aches) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: very mild arm pain in his left arm with first vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (very mild arm pain in his left arm with first vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Lot# 039A21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension (The patient reports that he has High blood pressure for 10 years). Concomitant products included LISINOPRIL for an unknown indication.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (very mild arm pain in his left arm with first vaccine). At the time of the report, PAIN IN EXTREMITY (very mild arm pain in his left arm with first vaccine) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The treatment information was not provided.   This case was linked to MOD-2021-114243 (Patient Link).
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain
Clinical narrative: low fever around 100 degrees F; Sore arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PYREXIA (low fever around 100 degrees F) and VACCINATION SITE PAIN (Sore arm) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (Tested positive for COVID in December. Patient has been tested for COVID several times since then with the last time being in February-all tests have come back positive.). Concurrent medical conditions included Lung disorder, Heart disorder, Diabetes and Deaf.    On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, the patient experienced PYREXIA (low fever around 100 degrees F) and VACCINATION SITE PAIN (Sore arm). On 29-Apr-2021, PYREXIA (low fever around 100 degrees F) and VACCINATION SITE PAIN (Sore arm) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Pyrexia
Clinical narrative: dry cough; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (dry cough), PYREXIA (fever) and CHILLS (chills) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-May-2021, the patient experienced PYREXIA (fever) and CHILLS (chills). On 05-May-2021, the patient experienced COUGH (dry cough). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 04-May-2021, PYREXIA (fever) and CHILLS (chills) had resolved. At the time of the report, COUGH (dry cough) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided Treatment medication include Tylenol .  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Incorrect dose administered, Pain in extremity, Vaccination site pain
Clinical narrative: This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (pain has been steady and consistent for the last four (4) months), INCORRECT DOSE ADMINISTERED (woman administering my second dose just jabbed the needle in one hand), PAIN IN EXTREMITY (severe pain in the left arm), VACCINATION SITE PAIN (Her arm is still sore  at the injection site) and CHILLS (The patient experienced chills the day of the vaccine) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 036A1A) for COVID-19 vaccination. The patient's past medical history included Stent placement. Concurrent medical conditions included Thyroid disorder and Cardiac dysfunction (Long Q-t syndrome). Concomitant products included PANTOPRAZOLE for Acid reflux (esophageal), FAMOTIDINE for Acid reflux (oesophageal), METOPROLOL and LISINOPRIL for Cardiac dysfunction, ATORVASTATIN for Cholesterol. On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 31-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain has been steady and consistent for the last four (4) months), INCORRECT DOSE ADMINISTERED (woman administering my second dose just jabbed the needle in one hand), PAIN IN EXTREMITY (severe pain in the left arm), VACCINATION SITE PAIN (Her arm is still sore  at the injection site) and CHILLS (The patient experienced chills the day of the vaccine). On 01-Apr-2021, CHILLS (The patient experienced chills the day of the vaccine) had resolved. At the time of the report, PAIN IN EXTREMITY (pain has been steady and consistent for the last four (4) months), PAIN IN EXTREMITY (severe pain in the left arm) and VACCINATION SITE PAIN (Her arm is still sore  at the injection site) had not resolved and INCORRECT DOSE ADMINISTERED (woman administering my second dose just jabbed the needle in one hand) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment included a steroid, not otherwise specified. This case was linked to US-MODERNATX, INC.-MOD-2021-114379 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Significant FU- Event outcome, concomitant, Medical condition updated; Sender's Comments: US-MODERNATX, INC.-MOD-2021-114379:MOD21-088160.
Sex: U
Vaccine: COVID19
Symptoms: Menstrual disorder
Clinical narrative: not gotten their periods; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of MENSTRUAL DISORDER (not gotten their periods) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MENSTRUAL DISORDER (not gotten their periods). At the time of the report, MENSTRUAL DISORDER (not gotten their periods) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site pain
Clinical narrative: Extremely tired; Vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Vaccination site pain) and FATIGUE (Extremely tired) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Iodine contrast media allergy, Atrial fibrillation since 2015 and Spinal stenosis (Spinal stenosis caused pinched nerves.) since 2010. Concomitant products included CALCIUM, VITAMIN C [ASCORBIC ACID] and VITAMIN B COMPLEX (B COMPLEX [VITAMIN B COMPLEX]) for an unknown indication.    On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Jan-2021, the patient experienced VACCINATION SITE PAIN (Vaccination site pain). On an unknown date, the patient experienced FATIGUE (Extremely tired). At the time of the report, VACCINATION SITE PAIN (Vaccination site pain) had resolved and FATIGUE (Extremely tired) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 09-Jun-2021: Medical History- Allergic to Iodine/Contrast.Other concomitant medications include Calcium, Vitamin C, B Complex.Sore arm event was recovered/resolved.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chest pain, Chills, Feeling abnormal, Nasopharyngitis
Clinical narrative: Stomach craping pain; Low pain in her chest; Feels choked up; Feels terrible/Feels like she got ran over by a diesel truck/Just don't feel good; Freezing; Several chills/Chills was so bad she had to use 4-5 covers to cover herself; Having really high fever; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach craping pain), CHEST PAIN (Low pain in her chest), FEELING ABNORMAL (Feels choked up), FEELING ABNORMAL (Feels terrible/Feels like she got ran over by a diesel truck/Just don't feel good) and NASOPHARYNGITIS (Freezing) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. CO2C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, the patient experienced ABDOMINAL PAIN UPPER (Stomach craping pain), CHEST PAIN (Low pain in her chest), FEELING ABNORMAL (Feels choked up), FEELING ABNORMAL (Feels terrible/Feels like she got ran over by a diesel truck/Just don't feel good), NASOPHARYNGITIS (Freezing), CHILLS (Several chills/Chills was so bad she had to use 4-5 covers to cover herself) and PYREXIA (Having really high fever). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. At the time of the report, ABDOMINAL PAIN UPPER (Stomach craping pain), CHEST PAIN (Low pain in her chest), FEELING ABNORMAL (Feels choked up), FEELING ABNORMAL (Feels terrible/Feels like she got ran over by a diesel truck/Just don't feel good), NASOPHARYNGITIS (Freezing), CHILLS (Several chills/Chills was so bad she had to use 4-5 covers to cover herself) and PYREXIA (Having really high fever) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No concomitant medications were provided. Lot number: CO2C21A (Patient said she could not see the writing very well so it could be COZC21A).
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Stomach craping pain; Low pain in her chest; Feels choked up; Feels terrible/Feels like she got ran over by a diesel truck/Just don't feel good; Freezing; Several chills/Chills was so bad she had to use 4-5 covers to cover herself; Having really high fever; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach craping pain), CHEST PAIN (Low pain in her chest), FEELING ABNORMAL (Feels choked up), FEELING ABNORMAL (Feels terrible/Feels like she got ran over by a diesel truck/Just don't feel good) and NASOPHARYNGITIS (Freezing) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. CO2C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, the patient experienced ABDOMINAL PAIN UPPER (Stomach craping pain), CHEST PAIN (Low pain in her chest), FEELING ABNORMAL (Feels choked up), FEELING ABNORMAL (Feels terrible/Feels like she got ran over by a diesel truck/Just don't feel good), NASOPHARYNGITIS (Freezing), CHILLS (Several chills/Chills was so bad she had to use 4-5 covers to cover herself) and PYREXIA (Having really high fever). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. At the time of the report, ABDOMINAL PAIN UPPER (Stomach craping pain), CHEST PAIN (Low pain in her chest), FEELING ABNORMAL (Feels choked up), FEELING ABNORMAL (Feels terrible/Feels like she got ran over by a diesel truck/Just don't feel good), NASOPHARYNGITIS (Freezing), CHILLS (Several chills/Chills was so bad she had to use 4-5 covers to cover herself) and PYREXIA (Having really high fever) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No concomitant medications were provided. Lot number: CO2C21A (Patient said she could not see the writing very well so it could be COZC21A).
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia
Clinical narrative: sore arm; Headache; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (sore arm) and HEADACHE (Headache) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 00C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  The patient's past medical history included COVID-19. Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.    On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, the patient experienced MYALGIA (sore arm) and HEADACHE (Headache). At the time of the report, MYALGIA (sore arm) and HEADACHE (Headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Cough, Rhinorrhoea
Clinical narrative: Nasal drip; Cough; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (Nasal drip) and COUGH (Cough) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Sinus infection since March 2021.    In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RHINORRHOEA (Nasal drip) and COUGH (Cough). At the time of the report, RHINORRHOEA (Nasal drip) and COUGH (Cough) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient was concern about drug interaction about using Doxycycline for a sinus infection. Concomitant product information was not provided. On 7 May 2021 patient was prescribed with Doxycycline by ENT physician.
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Erythema, Flushing, Pain in extremity, Vaccination site haemorrhage
Clinical narrative: flushing; red face and neck; bleeding at injection site; arm sore; face on fire; This spontaneous case was reported by a consumer and describes the occurrence of FLUSHING (flushing), ERYTHEMA (red face and neck), VACCINATION SITE HAEMORRHAGE (bleeding at injection site), PAIN IN EXTREMITY (arm sore) and BURNING SENSATION (face on fire) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FLUSHING (flushing), ERYTHEMA (red face and neck), VACCINATION SITE HAEMORRHAGE (bleeding at injection site), PAIN IN EXTREMITY (arm sore) and BURNING SENSATION (face on fire). At the time of the report, FLUSHING (flushing), ERYTHEMA (red face and neck), VACCINATION SITE HAEMORRHAGE (bleeding at injection site), PAIN IN EXTREMITY (arm sore) and BURNING SENSATION (face on fire) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided. No treatment information was reported.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pain, Pain in extremity
Clinical narrative: pain has been going on for about three months now; pain in different areas of her body including her knee, ankles, shoulders, and arms; pain in different areas of her body including her knee, ankles, shoulders, and arms; pain in different areas of her body including her knee, ankles, shoulders, and arms; pain in different areas of her body including her knee, ankles, shoulders, and arms; history of pain in those area prior to the vaccine but after the vaccine, her pain is more frequent; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in different areas of her body including her knee, ankles, shoulders, and arms), PAIN (history of pain in those area prior to the vaccine but after the vaccine, her pain is more frequent), PAIN (pain has been going on for about three months now), the first episode of ARTHRALGIA (pain in different areas of her body including her knee, ankles, shoulders, and arms) and the second episode of ARTHRALGIA (pain in different areas of her body including her knee, ankles, shoulders, and arms) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included GABAPENTIN and DICLOFENAC for an unknown indication.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Feb-2021, the patient experienced PAIN (history of pain in those area prior to the vaccine but after the vaccine, her pain is more frequent). On an unknown date, the patient experienced PAIN IN EXTREMITY (pain in different areas of her body including her knee, ankles, shoulders, and arms), PAIN (pain has been going on for about three months now), the first episode of ARTHRALGIA (pain in different areas of her body including her knee, ankles, shoulders, and arms), the second episode of ARTHRALGIA (pain in different areas of her body including her knee, ankles, shoulders, and arms) and the third episode of ARTHRALGIA (pain in different areas of her body including her knee, ankles, shoulders, and arms). At the time of the report, PAIN IN EXTREMITY (pain in different areas of her body including her knee, ankles, shoulders, and arms), PAIN (history of pain in those area prior to the vaccine but after the vaccine, her pain is more frequent), PAIN (pain has been going on for about three months now) and the last episode of ARTHRALGIA (pain in different areas of her body including her knee, ankles, shoulders, and arms) outcome was unknown.            No treatment medication were provided by the reporter.